53
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Manipulation of magnetic nanoparticle retention and hemodynamic consequences in microcirculation: assessment by laser speckle imaging

, , , &
Pages 2817-2827 | Published online: 11 Jun 2012

References

  • HafeliUOMagnetically modulated therapeutic systemsInt J Pharm2004277192415158965
  • NeubergerTSchopfBHofmannHHofmannMvon RechenbergBSuperparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery systemJ Magn Magn Mater2005293483496
  • VeisehOGunnJWZhangMDesign and fabrication of magnetic nanoparticles for targeted drug delivery and imagingAdv Drug Deliv Rev20106228430419909778
  • AlexiouCArnoldWKleinRJLocoregional cancer treatment with magnetic drug targetingCancer Res2000606641664811118047
  • AlexiouCJurgonsRSchmidRJMagnetic drug targeting: biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxanthine after locoregional cancer treatmentJ Drug Target20031113914913129824
  • MaYHWuSYWuTChangYJHuaMYChenJPMagnetically targeted thrombolysis with recombinant tissue plasminogen activator bound to polyacrylic acid-coated nanoparticlesBiomaterials2009303343335119299010
  • HuaMYLiuHLYangHWThe effectiveness of a magnetic nanoparticle-based delivery system for BCNU in the treatment of gliomasBiomaterials20113251652721030073
  • AlexiouCSchmidRJurgonsRTargeting cancer cells: magnetic nanoparticles as drug carriersEur Biophys J20063544645016447039
  • YangHWHuaMYLiuHLSelf-protecting core-shell magnetic nanoparticles for targeted, traceable, long half-life delivery of BCNU to gliomasBiomaterials2011326523653221645920
  • LubbeASBergemannCHuhntWPreclinical experiences with magnetic drug targeting: tolerance and efficacyCancer Res199656469447018840986
  • LubbeASBergemannCRiessHClinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumorsCancer Res199656468646938840985
  • WidderKJMorrisRMPooreGAHowardDPSenyeiAESelective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing ratsEur J Cancer Clin Oncol1983191351396682771
  • WilsonMWKerlanRKJrFidelmanNAHepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/conventional angiography suite – initial experience with four patientsRadiology200423028729314695402
  • WidderKJMarinoPAMorrisRMHowardDPPooreGASenyeiAESelective targeting of magnetic albumin microspheres to the Yoshida sarcoma: ultrastructural evaluation of microsphere dispositionEur J Cancer Clin Oncol1983191411476682772
  • LubbeASBergemannCBrockJMcClureDGPhysiological aspects in magnetic drug-targetingJ Magn Magn Mater1999194149155
  • YiYKimJHKangHWOhHSKimSWSeoMHA polymeric nanoparticle consisting of mPEG-PLA-Toco and PLMA-COONa as a drug carrier: improvements in cellular uptake and biodistributionPharm Res20052220020815783067
  • AlexiouCSchmidtAKleinRHulinPBergemannCArnoldWMagnetic drug targeting: biodistribution and dependency on magnetic field strengthJ Magn Magn Mater2002252363366
  • RiviereCMartinaMSTomitaYMagnetic targeting of nanometric magnetic fluid loaded liposomes to specific brain intravascular areas: a dynamic imaging study in miceRadiology200724443944817562813
  • LiuHLHuaMYYangHWMagnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brainProc Natl Acad Sci U S A2010107152051521020696897
  • FloresGALiuJIn-vitro blockage of a simulated vascular system using magnetorheological fluids as a cancer therapyEur Cell Mater2002391114562253
  • HallmarkBDartonNJHanXPalitSMackleyMRSlaterNKHObservation and modelling of capillary flow occlusion resulting from the capture of superparamagnetic nanoparticles in a magnetic fieldChem Eng Sci20086339603965
  • NacevABeniCShapiroBMagnetic nanoparticle transport within flowing blood and into surrounding tissueNanomedicine201051459146621128726
  • TurnerRDRandRWBentsonJRMossoJAFerromagnetic silicone necrosis of hypernephromas by selective vascular occlusion to the tumor: a new techniqueJ Urol19751134554591117515
  • WeisslederRStarkDDEngelstadBLSuperparamagnetic iron oxide: pharmacokinetics and toxicityAm J Roentgenol19891521671732783272
  • MaYHHsuYWChangYJHuaMYChenJPWuTIntra-arterial application of magnetic nanoparticle for targeted thrombolytic therapy: a rat embolic modelJ Magn Magn Mater2007311342346
  • JanschMStumpfPGrafCRuhlEMullerRHAdsorption kinetics of plasma proteins on ultrasmall superparamagnetic iron oxide (USPIO) nanoparticlesInt J Pharm
  • BriersJDFercherAFRetinal blood-flow visualization by means of laser speckle photographyInvest Ophthalmol Vis Sci1982222552597056639
  • ChenJPYangPCMaYHLuYJCharacterization of chitosan magnetic nanoparticles for in situ delivery of tissue plasminogen activatorCarbohydr Polym201184364372
  • AndersonGLAclandRDSiemionowMMcCabeSJVascular isolation of the rat cremaster muscleMicrovasc Res19883656633185303
  • DartonNJHallmarkBHanXPalitSSlaterNKHMackleyMRThe in-flow capture of superparamagnetic nanoparticles for targeting therapeuticsNanomedicine20084192918093881
  • BrixGStriethSStrelczykDStatic magnetic fields affect capillary flow of red blood cells in striated skin muscleMicrocirculation200815152617952798
  • GreishKEnhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicinesJ Drug Target20071545746417671892